Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/16/25/0b/16250b73-b698-5bbb-c580-5eb5eaf9d04c/mza_13167821798272810073.jpg/600x600bb.jpg
Oncology Unscripted With John Marshall
John Marshall
23 episodes
1 week ago
Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.
Show more...
Language Learning
Education
RSS
All content for Oncology Unscripted With John Marshall is the property of John Marshall and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.
Show more...
Language Learning
Education
https://image.simplecastcdn.com/images/ec61b327-3a4f-4bed-a4d2-7c7d2df62891/71aab300-abc4-4e89-95d3-bf5b076b52ea/3000x3000/ep-22-podcast-3000x3000.jpg?aid=rss_feed
Oncology Unscripted With John Marshall: Episode 22: ESMO, Efficiency, and Evidence: A Look Ahead at New Data and Important Updates
Oncology Unscripted With John Marshall
33 minutes 14 seconds
1 month ago
Oncology Unscripted With John Marshall: Episode 22: ESMO, Efficiency, and Evidence: A Look Ahead at New Data and Important Updates
Main Topic: In this Oncology Unscripted segment, Dr Marshall highlights upcoming ESMO presentations, including emerging trends in precision oncology and ctDNA-driven treatment strategies. He also discusses other important updates, including China’s growing role in clinical research and oncology treatment. Interview: In this episode of Candid Conversations, genitourinary cancer expert Dr Thomas Powles joins Dr Marshall to discuss how measurable residual disease (MRD), as assessed by circulating tumor DNA (ctDNA), is reshaping patient selection for adjuvant therapy. MedBuzz: In this MedBuzz, Dr Marshall pauses to reflect on a subtle but powerful shift he has noted in the hospital where the once-solid sense of teamwork and emotional safety now feels strained. After an unexpectedly emotional moment while on stage at a recent meeting, he asks an essential question: how are you holding up?
Oncology Unscripted With John Marshall
Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.